Literature DB >> 27547829

EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITRO.

John Z Q Luo1, Joseph W Kim2, LuGuang Luo2.   

Abstract

Ginseng has attracted interest because of its potential therapeutic role in diabetes therapy. No direct evidence has shown the effects of ginseng and its components, ginsenosides, on human islet β cell. In this study, we evaluated ginseng extract and ginsenosides (Rb2, Re, Rg1, Rd) on human pancreatic β cell function. The results provide direct evidence that ginseng extract promotes human pancreatic β cell function. Ginsenoside Rb2 increased islet β cell insulin release and promoted β cell migration. Ginsenoside Re had some impact on cell migration, but had no effect on islet function by evaluating insulin release. The other ginsenosides had no effect on insulin release and islet migration. To date, this is the first study that examines the impact of ginsenosides on human pancreatic islets in vitro.

Entities:  

Keywords:  American Ginseng; Diabetes; Ginsenosides; Human islets; Insulin; β cells

Year:  2016        PMID: 27547829      PMCID: PMC4991827     

Source DB:  PubMed          Journal:  Eur J Pharm Med Res        ISSN: 2394-3211


  81 in total

1.  Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS.

Authors:  William C S Cho; Tai-Tung Yip; Wai-Shing Chung; Sally K W Lee; Albert W N Leung; Christopher H K Cheng; Kevin K M Yue
Journal:  J Ethnopharmacol       Date:  2006-05-20       Impact factor: 4.360

2.  Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial.

Authors:  S W Ma; I F F Benzie; T T W Chu; B S P Fok; B Tomlinson; L A H Critchley
Journal:  Diabetes Obes Metab       Date:  2008-03-18       Impact factor: 6.577

3.  Ginseng therapy in non-insulin-dependent diabetic patients.

Authors:  E A Sotaniemi; E Haapakoski; A Rautio
Journal:  Diabetes Care       Date:  1995-10       Impact factor: 19.112

4.  Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice.

Authors:  John G Babish; Linda M Pacioretty; Jeffrey S Bland; Deanna M Minich; Jeffrey Hu; Matthew L Tripp
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

5.  Supplementation of cheonggukjang and red ginseng cheonggukjang can improve plasma lipid profile and fasting blood glucose concentration in subjects with impaired fasting glucose.

Authors:  Su-Kyung Shin; Joong-Ho Kwon; Yong-Jin Jeong; Seon-Min Jeon; Ji-Young Choi; Myung-Sook Choi
Journal:  J Med Food       Date:  2010-12-04       Impact factor: 2.786

6.  Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes.

Authors:  V Vuksan; M P Stavro; J L Sievenpiper; U Beljan-Zdravkovic; L A Leiter; R G Josse; Z Xu
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

7.  Construction of tissue-engineered homograft bioprosthetic heart valves in vitro.

Authors:  Feng Bin; Liu Yinglong; Xie Nin; Feng Kai; Son Laifeng; Zhu Xiaodong
Journal:  ASAIO J       Date:  2006 May-Jun       Impact factor: 2.872

8.  Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD.

Authors:  Jian-Bo Wan; Shao-Ping Li; Jun-Ming Chen; Yi-Tao Wang
Journal:  J Sep Sci       Date:  2007-04       Impact factor: 3.645

9.  Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis in MIN6N8 Pancreatic beta-Cells.

Authors:  Kyong Kim; Min Park; Hye Young Kim
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

10.  Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice.

Authors:  Hai Dan Yuan; Hai Yan Quan; Mi Song Jung; Su Jung Kim; Bo Huang; Do Yeon Kim; Sung Hyun Chung
Journal:  J Ginseng Res       Date:  2011-09       Impact factor: 6.060

View more
  4 in total

Review 1.  Ginsenoside Rb2: A review of pharmacokinetics and pharmacological effects.

Authors:  Longxing Miao; Yijun Yang; Zhongwen Li; Zengjun Fang; Yongqing Zhang; Chun-Chao Han
Journal:  J Ginseng Res       Date:  2021-11-19       Impact factor: 5.735

Review 2.  New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.

Authors:  Zezheng Gao; Qingwei Li; Xuemin Wu; Xuemin Zhao; Linhua Zhao; Xiaolin Tong
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818

3.  Cytoprotective effects of ginsenoside Rd on apoptosis-associated cell death in the isolated human pancreatic islets.

Authors:  Maryam Kaviani; Somayeh Keshtkar; Negar Azarpira; Mahdokht Hossein Aghdaei; Bita Geramizadeh; Mohammad Hossein Karimi; Ramin Yaghobi; Elaheh Esfandiari; Alireza Shamsaeefar; Saman Nikeghbalian; Ismail H Al-Abdullah
Journal:  EXCLI J       Date:  2019-08-22       Impact factor: 4.068

4.  Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.

Authors:  Qun Liu; Fei-Ge Zhang; Wen-Song Zhang; An Pan; Yi-Lin Yang; Jin-Feng Liu; Ping Li; Bao-Lin Liu; Lian-Wen Qi
Journal:  Theranostics       Date:  2017-09-20       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.